These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19903496)

  • 1. Study of Andes virus entry and neutralization using a pseudovirion system.
    Ray N; Whidby J; Stewart S; Hooper JW; Bertolotti-Ciarlet A
    J Virol Methods; 2010 Feb; 163(2):416-23. PubMed ID: 19903496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-
    Vial C; Whitaker A; Wilhelm J; Ovalle J; Perez R; Valdivieso F; Ferres M; Martinez-Valdebenito C; Eisenhauer P; Mertz GJ; Hooper JW; Botten JW; Vial PA
    Front Cell Infect Microbiol; 2020; 10():444. PubMed ID: 33042854
    [No Abstract]   [Full Text] [Related]  

  • 3. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.
    Kwilas S; Kishimori JM; Josleyn M; Jerke K; Ballantyne J; Royals M; Hooper JW
    Curr Gene Ther; 2014; 14(3):200-10. PubMed ID: 24867065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a lentiviral vector system to study the role of the Andes virus glycoproteins.
    Cifuentes-Muñoz N; Darlix JL; Tischler ND
    Virus Res; 2010 Oct; 153(1):29-35. PubMed ID: 20619306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Andes virus M genome segment is not sufficient to confer the virulence associated with Andes virus in Syrian hamsters.
    McElroy AK; Smith JM; Hooper JW; Schmaljohn CS
    Virology; 2004 Aug; 326(1):130-9. PubMed ID: 15262501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay.
    Kinoshita H; Yamada S; Ogawa T; Nguyen PHA; Harada S; Kawahara M; Ishijima K; Maeda K; Ebihara H; Fukushi S
    mBio; 2024 Jul; 15(7):e0109224. PubMed ID: 38847539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.
    Brown KS; Safronetz D; Marzi A; Ebihara H; Feldmann H
    J Virol; 2011 Dec; 85(23):12781-91. PubMed ID: 21917979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.
    Slough MM; Chandran K; Jangra RK
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability.
    Pepini T; Gorbunova EE; Gavrilovskaya IN; Mackow JE; Mackow ER
    J Virol; 2010 Nov; 84(22):11929-36. PubMed ID: 20844033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.
    Hooper JW; Ferro AM; Wahl-Jensen V
    J Virol; 2008 Feb; 82(3):1332-8. PubMed ID: 18032485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses.
    Warner BM; Stein DR; Jangra RK; Slough MM; Sroga P; Sloan A; Frost KL; Booth S; Chandran K; Safronetz D
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31337019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.
    Duehr J; McMahon M; Williamson B; Amanat F; Durbin A; Hawman DW; Noack D; Uhl S; Tan GS; Feldmann H; Krammer F
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).
    Brocato R; Josleyn M; Ballantyne J; Vial P; Hooper JW
    PLoS One; 2012; 7(4):e35996. PubMed ID: 22558299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling.
    Spiropoulou CF; Albariño CG; Ksiazek TG; Rollin PE
    J Virol; 2007 Mar; 81(6):2769-76. PubMed ID: 17202220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.
    Prescott J; DeBuysscher BL; Brown KS; Feldmann H
    Viruses; 2014 Jan; 6(2):516-23. PubMed ID: 24492621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalent VSV Vectors Mediate Rapid and Potent Protection from Andes Virus Challenge in Hamsters.
    Marceau J; Safronetz D; Martellaro C; Marzi A; Rosenke K; Feldmann H
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain.
    Matthys VS; Gorbunova EE; Gavrilovskaya IN; Mackow ER
    J Virol; 2010 Jan; 84(1):352-60. PubMed ID: 19846530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase.
    Kaku Y; Noguchi A; Marsh GA; Barr JA; Okutani A; Hotta K; Bazartseren B; Fukushi S; Broder CC; Yamada A; Inoue S; Wang LF
    J Virol Methods; 2012 Jan; 179(1):226-32. PubMed ID: 22115786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of protective immunity in a Syrian hamster model against a cytopathogenic strain of Andes virus.
    Martinez VP; Padula PJ
    J Med Virol; 2012 Jan; 84(1):87-95. PubMed ID: 22095538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.